In this online conversation, Jacki Davis talks to Nathalie Moll, Director-General of EFPIA – the European Federation of Pharmaceutical Industries and Associations, which supported the work on a recent ECIPE study entitled “The Benefits of Intellectual Property Rights in EU Free Trade Agreements”.
They discuss the importance of strong IP provisions in EU trade agreements, the European Commission’s revision of a Pharmaceutical Strategy, and the proposal of Industrial Strategy. Ms Moll explains how important these strategies are for the industry and the principal risks and opportunities related to the pharmaceutical strategy.
